Flora Growth's New CBD Formulation To Prevent Infection From COVID 19, Pending Regulatory Approval To Launch Clinical Trials
Cannabis producer Flora Growth Corp. (NASDAQ: FLGC) announced today that its seeking approval from INVIMA, the Colombian FDA, to begin research on their patent-pending, cannabinoid-based product, citing recent studies stating the possibility of cannabinoids to display viral inhibition.
